New Year, New Opportunities
🎉Happy New Year! 🎉 We hope you had time to rest and refresh.
As we step into 2024, we’re excited to continue to bring the latest information and tackle the challenges and opportunities that lie ahead in the field of fatty liver disease. The beginning of the year signals a fresh start, filled with renewed energy and the promise of new opportunities.
2023 concluded on a high note for liver health, and we can’t wait to build on that momentum throughout the coming months. As we usher in January, let’s look at the exciting developments and initiatives awaiting us.
Global Fatty Liver Day – 6 months to go!! 🥳
Formerly known as International NASH Day
Fatty liver disease often lurks undetected, impacting millions worldwide and serving as a significant risk factor for concurrent conditions. Left unchecked, it may progress to severe complications, including cirrhosis, liver cancer, and the need for a liver transplant.
Your involvement matters. The support from our partners is instrumental in the success of our campaign, and we invite you to stand with patients, advocate for early detection, and passionately champion the movement. By becoming an official partner, you’ll join a global network committed to making a positive impact.
Join us for Global Fatty Liver Day 2024 and visit our Partner Application page.
Veterans Health: Navigating Fatty Liver Disease from Risk Awareness to Diagnosis
A significant portion of U.S. Veterans, nearly a third, face the risk or are currently grappling with liver disease, with many cases going undiagnosed. Recognizing the importance of equitable access to information and support, GLI is dedicated to aiding veterans in navigating and understanding fatty liver disease, from early identification to diagnosis.
Empowering Primary Care: GLI and PRIME Inc. Collaborate on Fatty Liver Disease Resource
Global Liver Institute partnered with PRIME INC. to create a resource for primary care providers, focusing on early detection and intervention for fatty liver disease. The continuing education* resource addresses diagnostic delays and emphasizes the critical role of endocrinology and primary care teams. An accompanying video provides practical insights from expert faculty and GLI Patient Ambassadors to empower healthcare professionals in managing fatty liver disease within their clinical practice.
*PRIME® designates this activity for 0.5 contact hour.
Global Liver Institute Releases 2nd Edition of the Global State of Liver Health Report
Explore global perspectives on the factors and care that affect liver disease in our latest edition of The Global State of Liver Health report! Leading experts share insights into best practices and challenges, providing a comprehensive view of liver health worldwide. Discover where local experts advocate for change and the strategies that have proven successful.
Surfing the MASH Tsunami: Wrapping up 2023 – An Interview with Donna Cryer
Global Liver Institute Founder and CEO Donna Cryer joins Louise Campbell and Roger Green, on an episode of Surfing the MASH Tsunami, to discuss her personal challenges during the last part of 2023, the growing strength of GLI and the challenges facing GLI and the entire community in 2024.
The Silent Threat: Liver Cancer and NAFLD in Diabetics
A middle-aged man diagnosed with NAFLD and diabetes three years ago opted for alternative therapies instead of conventional medical treatment. Unfortunately, his condition deteriorated, resulting in a stage four liver cancer diagnosis, emphasizing the critical importance of adhering to medical treatment and the potential risks of relying solely on alternative therapies, as highlighted by Dr. Cyriac Abby Philips, also known as TheLiverDoc. The case underscores the link between NAFLD, diabetes, and liver cancer, emphasizing the need for preventive measures, including hepatitis B vaccination and regular monitoring for at-risk individuals.
